IHC analysis revealed more NOD1‐positive cells in glioma tissues than in non‐tumor tissues, with high‐grade gliomas having a markedly greater proportion of NOD1‐positive cells than low‐grade gliomas (p < 0.01, Figure 1B). This evidence concerns the gene NOD1 and central nervous system cancer.